Aquila's Lunch And Learn CDISC The FDA Data Standard. Disclosure Note 1/17/2014. Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC

Similar documents
Introduction to define.xml

Introduction to define.xml

MethodDefs, ValueLists and WhereClauses:

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Lex Jansen Octagon Research Solutions, Inc.

Updates on CDISC Standards Validation

Dataset-XML - A New CDISC Standard

Generating Define.xml Using SAS By Element-by-Element And Domain-by-Domian Mechanism Lina Qin, Beijing, China

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

Introduction to Define.xml

Implementing CDISC Using SAS. Full book available for purchase here.

Understanding the define.xml and converting it to a relational database. Lex Jansen, Octagon Research Solutions, Wayne, PA

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

Adding, editing and managing links to external documents in define.xml

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

Define.xml - Tips and Techniques for Creating CRT - DDS

Accessing and using the metadata from the define.xml. Lex Jansen, Octagon Research Solutions, Wayne, PA

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

A SAS based solution for define.xml

CDISC SDTM and ADaM Real World Issues

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA

XML4Pharma's ODM Study Designer New features of version 2010-R1 and 2010-R2

Advantages of a real end-to-end approach with CDISC standards

Define 2.0: What is new? How to switch from 1.0 to 2.0? Presented by FH-Prof.Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria

Traceability Look for the source of your analysis results

Study Data Technical Conformance Guide (TCG)

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata

How to handle different versions of SDTM & DEFINE generation in a Single Study?

Lex Jansen Octagon Research Solutions, Inc.

Material covered in the Dec 2014 FDA Binding Guidances

SDTM-ETL 3.1 User Manual and Tutorial

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Dealing with changing versions of SDTM and Controlled Terminology (CT)

SDTM-ETL 4.0 Preview of New Features

Now let s take a look

SAS 9.3 CDISC Procedure

How to write ADaM specifications like a ninja.

Mapping Corporate Data Standards to the CDISC Model. David Parker, AstraZeneca UK Ltd, Manchester, UK

Study Data Reviewer s Guide Completion Guideline

Linking Metadata from CDASH to ADaM Author: João Gonçalves Business & Decision Life Sciences, Brussels, Belgium

DIA 11234: CDER Data Standards Common Issues Document webinar questions

Legacy to SDTM Conversion Workshop: Tools and Techniques

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

PharmaSUG Paper AD03

Paper DS07. Generating Define.xml and Analysis Result Metadata using Specifications, Datasets and TFL Annotation

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

SAS offers technology to facilitate working with CDISC standards : the metadata perspective.

From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials

Introduction to ADaM and What s new in ADaM

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

Business & Decision Life Sciences

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences

SAS, XML, and CDISC. Anthony T Friebel XML Development Manager, SAS XML Libname Engine Architect SAS Institute Inc.

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

CDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume

Standards Implementation: It Should be Simple Right? Thursday January 18, 2018

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Define.xml tools supporting SEND/SDTM data process

Helping The Define.xml User

FDA XML Data Format Requirements Specification

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

CDISC Standards and the Semantic Web

Standards Metadata Management (System)

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Less is more - A visionary View on the Future of CDISC Standards

A SDTM Legacy Data Conversion

CS05 Creating define.xml from a SAS program

OpenCDISC Validator 1.4 What s New?

Why organizations need MDR system to manage clinical metadata?

Study Data Reviewer s Guide

CBER STUDY DATA STANDARDS UPDATE

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Standards Driven Innovation

CDISC Journal. Generating a cabig Patient Study Calendar from a Study Design in ODM with Study Design Model Extension. By Jozef Aerts.

What is high quality study metadata?

SAS Clinical Data Integration 2.6

esubmission - Are you really Compliant?

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

Implementing CDISC at Boehringer Ingelheim

define.xml: A Crash Course Frank DiIorio

CDISC Public Webinar Standards Updates and Additions. 26 Feb 2015

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization

PhUSE US Connect 2019

PhUSE EU Connect Paper PP15. Stop Copying CDISC Standards. Craig Parry, SyneQuaNon, Diss, England

Study Data Reviewer s Guide. FDA/PhUSE Project Summary

Experience of electronic data submission via Gateway to PMDA

Data Integrity through DEFINE.PDF and DEFINE.XML

SAS Clinical Data Integration 2.4

Converting Data to the SDTM Standard Using SAS Data Integration Studio

Catherine Hosage Norman, Ph.D., RAC. January 11, 2012

ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up

SDTM Attribute Checking Tool Ellen Xiao, Merck & Co., Inc., Rahway, NJ

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

Semantic Technologies and CDISC Standards. Frederik Malfait, Information Architect, IMOS Consulting Scott Bahlavooni, Independent

Transcription:

Aquila's Lunch And Learn CDISC The FDA Data Standard Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC Disclosure Note This free training session will be placed on Aquila s website after the session is complete. The video may include your webex name, your questions and any answers. By participating you agree to allowing Aquila to publish this information. Note: Datasets are publically available from NHANES or CDISC.org. Joshua Boutwell, MBA RAC 15 years of experience in research, Regulatory Affairs, Regulatory Operations and Publishing Founded Aquila Solutions in 2010 1

Today s Topics 1. Clinical Data and Submission Requirements 2. What is XPT? 3. Future FDA Requirements 4. 5. The Future for CDISC 6. Questions 7. The Next Lunch And Learn Clinical Data and Submission Requirements Phase 3 CSR s can be over 20,000 pages long Under 21 CFR 314.50 sponsors are required to submit statistical data This data can be hundreds to thousands of Megabytes per study Clinical Data and Submission Requirements Current Requirements: All Phase 2 and 3 CSRs must include a clinical database unless specifically exempted by FDA The data must be presented in a method that the FDA can incorporate and analyze easily You are required to use SAS Transport File extension XPT 2

Today s Topics 1. Clinical Data and Submission Requirements 2. What is XPT? 3. Future FDA Requirements 4. 5. The Future for CDISC 6. Questions 7. The Next Lunch And Learn What is XPT? XPT is a Human Readable format called SAS Transport What is XPT? XPT is an open, Human Readable format Called SAS Transport 3

What is XPT? I recommend using software: SAS Universal Viewer: http://goo.gl/ajvjio What is XPT? The XPT format allows you to create: Tables with unlimited size Define unlimited variables Allows descriptive variable names To represent any type of data What goes into a Database? 4

What goes into a Legacy Database? 1. XPT files (unlimited number) Contains your data No restriction on field names No guidance on table names What goes into a Legacy Database? 2. Define.pdf (1 per database) Includes a table to describe your XPTs Must identify the data type and source Links to XPT and annotated CRF as appropriate What goes into a Legacy Database? 3. Annotated CRF (1 per tabulation Database) A blank copy of the CRF used in the Clinical Study Text identify the table and variable name of every blank Links to Define.PDF 5

What goes into a Legacy Database? 4. Programs (multiple per Analysis Database) The programs that create the Analysis database Typically programmed in SAS language Provide as both txt (.SAS extension) and PDF The Problem Every Study database is different. Most studies have almost identical data types yet 1. Programs can not be reused 2. Navigation must be relearned 3. Data cannot be correlated between studies Today s Topics 1. Clinical Data and Submission Requirements 2. What is XPT? 3. Future FDA Requirements 4. 5. The Future for CDISC 6. Questions 7. The Next Lunch And Learn 6

Future FDA Requirements FDA has been working to standardize data packages for years Implemented the JANUS computer system Develop CDISC standards Strongly recommend conversion But on September 13, 2013 it became official Future FDA Requirements http://www.fda.gov/forindustry/datastandards/studydatastandards/ucm368613.htm Position Statement FDA recognizes the investment made by sponsors over the past decade to develop the expertise and infrastructure to utilize Clinical Data Interchange Standards Consortium (CDISC)[1] standards for study data. The submission of standardized study data enhances a reviewer s ability to more fully understand and characterize the efficacy and safety of a medical product. The Prescription Drug User Fee Act (PDUFA V) Performance Goals state that FDA will develop guidance for industry on the use of CDISC data standards for the electronic submission of study data in applications. In the near future, FDA will publish guidance that will require study data in conformance to CDISC standards. FDA envisions a semantically interoperable and sustainable submission environment that serves both regulated clinical research and health care. To this end, FDA will continue to research and evaluate, with its stakeholders, potential new approaches to current and emerging data standards. FDA does not foresee the replacement of CDISC standards for study data and will not implement new approaches without public input on the cost and utility of those approaches. Future FDA Requirements Aquila Predictions: 1. A draft guidance release in 2014 Q3/Q4 2. Updated and Active by 2016 3. For CDISC requirement on or around PDUFA VI (2017) 4. Probably a 2 year implementation period 5. Existing studies will probably be exempt. These are our predictions. They are not binding on Aquila or anyone else! 7

Today s Topics 1. Clinical Data and Submission Requirements 2. What is XPT? 3. Future FDA Requirements 4. 5. The Future for CDISC 6. Questions 7. The Next Lunch And Learn CDISC is: 1. A strict naming convention for XPT file names 2. A strict naming convention for Field names 3. Rules for handling unusual data 4. A DTD and stylesheet for an XML replacement to the Define.pdf (define.xml) CDISC Components: SDTM Study Data Tagging Model ADaM Analysis Data Model 8

A define.xml for SDTM Database A define.xml for SDTM Database (as XML code) <?xml version="1.0" encoding="utf 8"?> <?xml stylesheet type="text/xsl" href="../stylesheets/define2 0 0.xsl"?> <ODM xmlns="http://www.cdisc.org/ns/odm/v1.3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:def="http://www.cdisc.org/ns/def/v2.0" ODMVersion="1.3.2" FileOID="www.cdisc.org.Studycdisc01 Define XML_2.0.0" FileType="Snapshot" CreationDateTime="2013 03 03T17:04:44" Originator="CDISC XML Technologies Team" SourceSystem="MH System" SourceSystemVersion="2.0.1" > <! ****************************************** > <! OID conventions used in this example: > <! MetaDataVersion = MDV. > <! def:leaf, leafid LF. > = <! def:valuelistdef = VL. > <! def:whereclausedef = WC. > <! ItemGroupDef = IG. > <! ItemDef IT. = > <! CodeList = CL. > <! MethodDef = MT. > <! def:commentdef = COM. > <! ****************************************** > <! ****************************************** > <! This example does not include Value Level > <! Metadata (def:valuelistdef) for all items > <! that may need separate definitions. > <! The cases included are included for > <! illustration purposes only. > <! ****************************************** > <def:annotatedcrf> <def:documentref leafid="lf.blankcrf"/> </def:annotatedcrf> <def:supplementaldoc> <def:documentref leafid="lf.reviewersguide"/> <def:documentref leafid="lf.complexalgorithms"/> </def:supplementaldoc> <def:valuelistdef OID="VL.DA.DAORRES"> <ItemRef ItemOID="IT.DA.DAORRES.DISPAMT" OrderNumber="1" Mandatory="Yes"> <def:whereclauseref WhereClauseOID="WC.DA.DATESTCD.DISPAMT"/> <ItemRef ItemOID="IT.DA.DAORRES.RETAMT" OrderNumber="2" Mandatory="No"> <def:whereclauseref WhereClauseOID="WC.DA.DATESTCD.RETAMT"/> </def:valuelistdef> <def:valuelistdef OID="VL.EG.EGORRES"> <ItemRef ItemOID="IT.EG.EGORRES.INTP" OrderNumber="1" Mandatory="No"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.INTP"/> <ItemRef ItemOID="IT.EG.EGORRES.PRMEAN" OrderNumber="2" Mandatory="No"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.PRMEAN"/> <ItemRef ItemOID="IT.EG.EGORRES.QRSDUR" OrderNumber="3" Mandatory="No"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.QRSDUR"/> <ItemRef ItemOID="IT.EG.EGORRES.QTMEAN" OrderNumber="4" Mandatory="No"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.QTMEAN"/> <ItemRef ItemOID="IT.EG.EGORRES.VRMEAN" OrderNumber="5" Mandatory="No"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.VRMEAN"/> </def:valuelistdef> <def:valuelistdef OID="VL.EG.EGSTRESC"> <ItemRef ItemOID="IT.EG.EGSTRESC.QTCB" OrderNumber="1" Mandatory="Yes" MethodOID="MT.QTCB"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.QTCB"/> <ItemRef ItemOID="IT.EG.EGSTRESC.QTCF" OrderNumber="2" Mandatory="Yes" MethodOID="MT.QTCF"> <def:whereclauseref WhereClauseOID="WC.EG.EGTESTCD.QTCF"/> </def:valuelistdef> 9

A Demographic table for SDTM Database DM.xpt A Demographic table for unusual SDTM Database suppdm.xpt Issues with your Database Conversion It is difficult to convert legacy to CDISC 1. The data structure must be altered 2. Some data may not fit into the standard 3. Existing analysis programs will not work 4. Duplicates work. Plan ahead and design your biostats to use CDISC 10

Today s Topics 1. Clinical Data and Submission Requirements 2. What is XPT? 3. Future FDA Requirements 4. 5. The Future for CDISC 6. Questions 7. The Next Lunch And Learn The Future of CDISC CDISC is under continuous development. other models being developed are: SEND Standard for Exchange of Nonclinical Data (FDA Pilot Study Underway) CDASH Clinical Data Acquisition Standards Harmonization LAB Laboratory Data Model ODM Operational Data Model Aquila Can Help Aquila provides Data Package Review We assess your data package to ensure 1. The files are formatted correctly 2. The necessary data is included in the database 3. The define files and annotated CRF are correct 4. Verify your CDISC database is correct Aquila provides Database Conversion If FDA requires your data be submitted in CDISC, Aquila can convert a legacy database to CDISC and place it in your application. 11

Today s Topics 1. Clinical Data and Submission Requirements 2. What is XPT? 3. Future FDA Requirements 4. 5. The Future for CDISC 6. Questions 7. The Next Lunch And Learn Next Lunch and Learn : ecopy esubmissions and devices Topics: 1. What is ecopy 2. Where is it required 3. Things to consider February 7 th 2014 1 PM 1:30 PM EST 15 minute training with 15 minute Q/A http://www.aquilasolutions.us/training 2014 02 07 12